PetMed Express (NASDAQ:PETS) Releases Earnings Results, Misses Expectations By $0.45 EPS

PetMed Express (NASDAQ:PETS) announced its earnings results on Friday. The company reported ($0.41) EPS for the quarter, missing the consensus estimate of $0.04 by ($0.45), reports. The company had revenue of $44.36 million for the quarter. PetMed Express had a negative net margin of 2.76% and a negative return on equity of 6.76%.

PetMed Express Price Performance

PetMed Express stock opened at $3.60 on Friday. PetMed Express has a 12 month low of $1.57 and a 12 month high of $5.58. The company has a fifty day moving average price of $2.37 and a two-hundred day moving average price of $2.88. The company has a market cap of $76.93 million, a PE ratio of -1.36 and a beta of 0.75.

Analyst Ratings Changes

A number of equities analysts have issued reports on PETS shares. Wall Street Zen lowered PetMed Express from a “hold” rating to a “sell” rating in a research report on Saturday, October 18th. Zacks Research raised shares of PetMed Express from a “strong sell” rating to a “hold” rating in a report on Monday, September 29th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of PetMed Express in a report on Wednesday, October 8th. One research analyst has rated the stock with a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Sell” and an average target price of $3.20.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the business. Man Group plc grew its position in shares of PetMed Express by 7.1% during the 3rd quarter. Man Group plc now owns 151,039 shares of the company’s stock valued at $379,000 after buying an additional 9,989 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in PetMed Express by 59.3% in the first quarter. Goldman Sachs Group Inc. now owns 33,209 shares of the company’s stock valued at $139,000 after acquiring an additional 12,360 shares during the period. Occudo Quantitative Strategies LP bought a new position in shares of PetMed Express during the second quarter valued at approximately $51,000. Oxford Asset Management LLP acquired a new stake in shares of PetMed Express during the 2nd quarter worth approximately $55,000. Finally, Bridgeway Capital Management LLC raised its position in shares of PetMed Express by 96.2% during the 2nd quarter. Bridgeway Capital Management LLC now owns 40,800 shares of the company’s stock worth $135,000 after purchasing an additional 20,000 shares during the period. 73.33% of the stock is owned by institutional investors and hedge funds.

PetMed Express Company Profile

PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.

Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.